Bioage Labs Inc.
06/12/2026 | Press release | Distributed by Public on 06/12/2026 06:00
Proxy Results (Form 8-K)
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 10, 2026, BioAge Labs, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders and the Company's stockholders voted on and approved the following proposals:
1.
The election of three Class II Directors, Patrick Enright, M.B.A., James I. Healy, M.D., Ph.D., and Rekha Hemrajani, M.B.A., each to serve a three-year term, which will expire at the 2029 Annual Meeting of Stockholders and until such time as their respective successors have been duly elected and qualified or until such director's earlier resignation or removal. The vote tally was as follows:
|
Nominees |
Shares For |
Shares Withheld |
Broker Non-Votes |
|
Patrick Enright, M.B.A. |
30,075,928 |
1,184,271 |
5,327,405 |
|
James I. Healy, M.D., Ph.D. |
25,499,205 |
5,760,994 |
5,327,405 |
|
Rekha Hemrajani, M.B.A. |
27,826,781 |
3,433,418 |
5,327,405 |
2.
The ratification of the appointment of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. The vote tally was as follows:
|
Shares For |
Shares Against |
Shares Abstaining |
|
36,561,171 |
1,305 |
25,128 |
Bioage Labs Inc. published this content on June 12, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 12, 2026 at 12:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]